Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-01-05
1992-05-19
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549292, A61K 3135, C07D30930
Patent
active
051149648
ABSTRACT:
Disclosed are novel aryl-substituted benzocycloalkyl-derived 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula: ##STR1## their corresponding dihydroxy acids, and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 4499289 (1985-02-01), Baran
patent: 4804679 (1989-02-01), Anderson
patent: 4863957 (1989-09-01), Neuenschwander
patent: 4892884 (1990-01-01), Neuenschwander
Haley Jacqueline
Lee Mary C.
Parker Raymond S.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Savitzky Martin F.
LandOfFree
Aryl-substituted benzocycloalkyl-derived anti-atherosclerotic ag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl-substituted benzocycloalkyl-derived anti-atherosclerotic ag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl-substituted benzocycloalkyl-derived anti-atherosclerotic ag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2417688